Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-14

Clinical Trial Update: ALFApump System Versus Standard of Care in Ascites Treatment [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the ALFApump System to standard of care for refractory or recurrent ascites has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALFApump System

Snippet

Sponsor: Sequana Medical N.V. | Conditions: Refractory or Recurrent Ascites | Phase 3 | Status: COMPLETED